Patient-reported outcomes in meta-analyses – Part 1: assessing risk of bias and combining outcomes
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1477-7525
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Patient-reported outcomes in meta-analyses – Part 1: assessing risk of bias and combining outcomes ; volume:11 ; number:1 ; day:1 ; month:7 ; year:2013 ; pages:1-10 ; date:12.2013
Health and quality of life outcomes ; 11, Heft 1 (1.7.2013), 1-10, 12.2013
- Creator
-
Johnston, Bradley C.
Patrick, Donald L.
Busse, Jason W.
Schünemann, Holger J.
Agarwal, Arnav
Guyatt, Gordon
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/1477-7525-11-109
- URN
-
urn:nbn:de:101:1-2019101700544252179940
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:37 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Johnston, Bradley C.
- Patrick, Donald L.
- Busse, Jason W.
- Schünemann, Holger J.
- Agarwal, Arnav
- Guyatt, Gordon
- SpringerLink (Online service)
Other Objects (12)
Der Kohlendioxidtransport im Organismus : Untersuchungen zur Kinetik des pulmonalen CO2-Austauschs und zum Einfluss des Laktats auf das oxylabile CO2
Improving the use of research evidence in guideline development: 6. Determining which outcomes are important
American Society of Hematology living guidelines on the use of anticoagulation for thromboprophylaxis in patients with COVID-19: May 2021 update on the use of intermediate-intensity anticoagulation in critically ill patients
Reviews: Rapid! Rapid! Rapid! …and systematic
American Society of Hematology living guidelines on the use of anticoagulation for thromboprophylaxis in patients with COVID-19: January 2022 update on the use of therapeutic-intensity anticoagulation in acutely ill patients
Using patient values and preferences to inform the importance of health outcomes in practice guideline development following the GRADE approach
Developing clinical practice guidelines: types of evidence and outcomes; values and economics, synthesis, grading, and presentation and deriving recommendations
Improving the use of research evidence in guideline development: 12. Incorporating considerations of equity
Improving the use of research evidence in guideline development: 16. Evaluation
American Society of Hematology living guidelines on the use of anticoagulation for thromboprophylaxis for patients with COVID-19 : : March 2022 update on the use of anticoagulation in critically ill patients
Improving the use of research evidence in guideline development: 5. Group processes
Improving the use of research evidence in guideline development: 14. Reporting guidelines
Der Kohlendioxidtransport im Organismus : Untersuchungen zur Kinetik des pulmonalen CO2-Austauschs und zum Einfluss des Laktats auf das oxylabile CO2
Improving the use of research evidence in guideline development: 6. Determining which outcomes are important
American Society of Hematology living guidelines on the use of anticoagulation for thromboprophylaxis in patients with COVID-19: May 2021 update on the use of intermediate-intensity anticoagulation in critically ill patients
Reviews: Rapid! Rapid! Rapid! …and systematic
American Society of Hematology living guidelines on the use of anticoagulation for thromboprophylaxis in patients with COVID-19: January 2022 update on the use of therapeutic-intensity anticoagulation in acutely ill patients
Using patient values and preferences to inform the importance of health outcomes in practice guideline development following the GRADE approach
Developing clinical practice guidelines: types of evidence and outcomes; values and economics, synthesis, grading, and presentation and deriving recommendations
Improving the use of research evidence in guideline development: 12. Incorporating considerations of equity
Improving the use of research evidence in guideline development: 16. Evaluation
American Society of Hematology living guidelines on the use of anticoagulation for thromboprophylaxis for patients with COVID-19 : : March 2022 update on the use of anticoagulation in critically ill patients
Improving the use of research evidence in guideline development: 5. Group processes
Improving the use of research evidence in guideline development: 14. Reporting guidelines
Der Kohlendioxidtransport im Organismus : Untersuchungen zur Kinetik des pulmonalen CO2-Austauschs und zum Einfluss des Laktats auf das oxylabile CO2
Improving the use of research evidence in guideline development: 6. Determining which outcomes are important
American Society of Hematology living guidelines on the use of anticoagulation for thromboprophylaxis in patients with COVID-19: May 2021 update on the use of intermediate-intensity anticoagulation in critically ill patients
Reviews: Rapid! Rapid! Rapid! …and systematic
American Society of Hematology living guidelines on the use of anticoagulation for thromboprophylaxis in patients with COVID-19: January 2022 update on the use of therapeutic-intensity anticoagulation in acutely ill patients
Using patient values and preferences to inform the importance of health outcomes in practice guideline development following the GRADE approach
Developing clinical practice guidelines: types of evidence and outcomes; values and economics, synthesis, grading, and presentation and deriving recommendations
Improving the use of research evidence in guideline development: 12. Incorporating considerations of equity
Improving the use of research evidence in guideline development: 16. Evaluation
American Society of Hematology living guidelines on the use of anticoagulation for thromboprophylaxis for patients with COVID-19 : : March 2022 update on the use of anticoagulation in critically ill patients
Improving the use of research evidence in guideline development: 5. Group processes